Medicine and Dentistry
Hepatocellular Carcinoma
60%
Virus DNA
40%
Hepatitis B Virus
40%
Hazard Ratio
40%
Complication
30%
Disease Exacerbation
20%
Alanine Aminotransferase
20%
Hepatitis B
20%
Liver Cirrhosis
20%
Male
20%
Antivirus Agent
10%
Follow up
10%
Kaplan Meier Method
10%
Prognostic Factor
10%
Hepatitis
10%
Chronic Hepatitis B
10%
Bilirubin
10%
Hepatitis B(e) Antigen
10%
Transient Elastography
10%
Chronic Active Hepatitis
10%
Analysis
10%
Therapeutic Procedure
10%
Adjustment
10%
Nursing and Health Professions
Patient
100%
Confidence Interval
40%
Virus DNA
40%
Complication
30%
Prognosis
20%
Liver Cirrhosis
20%
Disease Exacerbation
20%
Alanine Aminotransferase
20%
Kaplan Meier Method
10%
Follow up
10%
Propensity Score
10%
Antivirus Agent
10%
Hepatitis
10%
Chronic Hepatitis B
10%
Hepatitis B(e) Antigen
10%
Bilirubin
10%
Analysis
10%
Transient Elastography
10%
Electric Potential
10%
Chronic Active Hepatitis
10%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
60%
Hepatitis B Virus
40%
Virus DNA
40%
Complication
30%
Disease Exacerbation
20%
Alanine Aminotransferase
20%
Hepatitis B
20%
Liver Cirrhosis
20%
Prognosis
20%
Antivirus Agent
10%
Hepatitis
10%
Bilirubin
10%
Chronic Hepatitis B
10%
Hepatitis B(e) Antigen
10%
Chronic Active Hepatitis
10%
Immunology and Microbiology
Hepatitis B Virus
40%
DNA Virus
40%
Electric Potential
10%
Hepatitis B
10%
Hepatitis
10%
Hepatitis B(e) Antigen
10%
Immunity
10%